Related Experiment Video
Updated: Jun 25, 2026

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
[Anticytokine therapy in sepsis and why it fails]
Václav Chýlek1, Roman Kula, Michal Holub
1Dept. of Anaesthesiology and Resuscitation, University Hospital Ostrava, Czech Republic. Vaclav.Chylek@seznam.cz
Abstract:
Anticytokine therapy in sepsis belongs to a subgroup of therapeutic interventions referred to as antiinflammatory or immunomodulatory strategies in the intensive care literature. Between the mid-1980s and the late 1990s, this approach was considered very promising. Against all expectations, it proved ineffective or even harmful in many cases. However, the recent literature is suggestive of a renewed interest in the topic. Therefore, we attempted at a retrospective search for causes of the failure.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hypersensitivity Reactions: Cytolytic Reactions
Pharmaceutical Poisoning: Treatment Strategies
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Bacterial Meningitis II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

